{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T19:24:42Z","timestamp":1794943482201,"version":"4.9.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203319"],"award-info":[{"award-number":["NIHR203319"]}],"id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.lanepe.2026.101722","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T23:51:01Z","timestamp":1779753061000},"page":"101722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver disease"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6466-1412","authenticated-orcid":false,"given":"Nicola","family":"Pugliese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trenton M.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8368-1478","authenticated-orcid":false,"given":"Paul N.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Pannain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Hagstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Rice-Duek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4325-3900","authenticated-orcid":false,"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrielle","family":"Caussy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2164-4476","authenticated-orcid":false,"given":"John F.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Kopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2655-8283","authenticated-orcid":false,"given":"Giada","family":"Sebastiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Boursier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel A.","family":"Tsochatzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8713-1481","authenticated-orcid":false,"given":"Willem Pieter","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Guaraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Vettor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1854-1924","authenticated-orcid":false,"given":"Maja","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8200-6382","authenticated-orcid":false,"given":"Michael","family":"Roden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Stefan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Jarvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Gines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rn M.","family":"Schattenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Pose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Buttigieg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6322-7753","authenticated-orcid":false,"given":"Christopher D.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9618-2299","authenticated-orcid":false,"given":"Jeffrey V.","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lanepe.2026.101722_bib1","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"issue":"13","key":"10.1016\/j.lanepe.2026.101722_bib2","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1016\/j.cgh.2025.02.007","article-title":"Steatotic liver disease classification is dynamic, affecting clinical trial eligibility and subclass-specific treatments","volume":"23","author":"Israelsen","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.lanepe.2026.101722_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra2412865","article-title":"Metabolic dysfunction-associated steatotic liver disease","volume":"393","author":"Targher","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101722_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.lanepe.2026.101722_bib5","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","article-title":"The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes","volume":"22","author":"Younossi","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.lanepe.2026.101722_bib6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101722_bib7","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.lanepe.2026.101722_bib8","first-page":"579","article-title":"Nonalcoholic fatty liver disease in children","volume":"17","author":"Sweeny","year":"2021","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.lanepe.2026.101722_bib9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s44360-026-00078-1","article-title":"Physical activity remains under-prioritized in political agendas","volume":"1","author":"Ram\u00edrez Varela","year":"2026","journal-title":"Nat Health"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101722_bib10","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101722_bib11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jhep.2025.03.001","article-title":"Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden","volume":"83","author":"Issa","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.lanepe.2026.101722_bib12","article-title":"A call for doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis","volume":"54","author":"Lazarus","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.lanepe.2026.101722_bib13","article-title":"Steatotic liver disease trajectory: a holistic EASL guidance on the multidisciplinary approach to screening and patient management\u2606","author":"Brouwer","year":"2026","journal-title":"JHEP Rep"},{"issue":"7","key":"10.1016\/j.lanepe.2026.101722_bib14","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/ueg2.70055","article-title":"Key predictors of relevant weight loss in patients with metabolic dysfunction-associated steatotic liver disease","volume":"13","author":"Pugliese","year":"2025","journal-title":"United European Gastroenterol J"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101722_bib15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.lanepe.2026.101722_bib16","article-title":"Non-invasive tests: Establishing efficacy for metabolic dysfunction-associated steatohepatitis beyond the biopsy-Current perspectives from the Division of Hepatology and Nutrition, US Food and Drug Administration","author":"Anania","year":"2025","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.lanepe.2026.101722_bib17","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1038\/s41591-024-02958-z","article-title":"Opportunities and challenges following approval of resmetirom for MASH liver disease","volume":"30","author":"Lazarus","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.lanepe.2026.101722_bib18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S2468-1253(25)00260-2","article-title":"Current and emerging therapeutic landscape for metabolic dysfunction-associated steatohepatitis","volume":"11","author":"Li","year":"2026","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.lanepe.2026.101722_bib19","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2023.34","article-title":"Treatment options and continuity of care in metabolic-associated fatty liver disease: a multidisciplinary approach","volume":"19","author":"Lara-Romero","year":"2024","journal-title":"Eur Cardiol"},{"issue":"10","key":"10.1016\/j.lanepe.2026.101722_bib20","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41575-024-00938-9","article-title":"Envisioning how to advance the MASH field","volume":"21","author":"Allen","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.lanepe.2026.101722_bib21","article-title":"Non-invasive tests for MetALD and alcohol-related liver disease","volume":"7","author":"Johansen","year":"2025","journal-title":"JHEP Rep"},{"issue":"7","key":"10.1016\/j.lanepe.2026.101722_bib22","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2337\/dci24-0094","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in people with diabetes: the need for screening and early intervention. A consensus report of the American Diabetes Association","volume":"48","author":"Cusi","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lanepe.2026.101722_bib23","article-title":"Implementation of evidence-based alcohol policies to reduce alcohol-related harm and liver disease to advance public health in Europe","volume":"65","author":"Pose","year":"2026","journal-title":"Lancet Reg Health Eur"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101722_bib24","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000649","article-title":"Multidisciplinary clinic model enhances liver and metabolic health outcomes in adults with MASH","volume":"9","author":"Stine","year":"2025","journal-title":"Hepatol Commun"},{"issue":"10","key":"10.1016\/j.lanepe.2026.101722_bib25","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1007\/s10620-024-08601-8","article-title":"Missed and delayed diagnoses of chronic liver disease in primary care patients with cirrhosis","volume":"69","author":"Patel","year":"2024","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101722_bib26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jhep.2019.05.033","article-title":"Intelligent liver function testing (iLFT): a trial of automated diagnosis and staging of liver disease in primary care","volume":"71","author":"Dillon","year":"2019","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.lanepe.2026.101722_bib27","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1136\/gutjnl-2023-330269","article-title":"Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation and electronic reminder messages: a randomised controlled trial","volume":"72","author":"Zhang","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.lanepe.2026.101722_bib28","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000001400","article-title":"Detecting at-risk steatotic liver disease and liver fibrosis in the community","author":"Adams","year":"2025","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101722_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2019.03.033","article-title":"Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease","volume":"71","author":"Srivastava","year":"2019","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101722_bib30","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/gutjnl-2023-330771","article-title":"Beyond a liver-gut focus: the evolution of gastroenterology and hepatology in challenging the obesity and steatotic liver disease paradigm","volume":"73","author":"Brennan","year":"2024","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101722_bib31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12875-024-02517-y","article-title":"Deploying a metabolic dysfunction-associated steatohepatitis consensus care pathway: findings from an educational pilot in three health systems","volume":"25","author":"Kumar","year":"2024","journal-title":"BMC Prim Care"},{"issue":"10","key":"10.1016\/j.lanepe.2026.101722_bib32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41575-021-00477-7","article-title":"Defining comprehensive models of care for NAFLD","volume":"18","author":"Lazarus","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101722_bib33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jhep.2023.01.026","article-title":"Healthcare and socioeconomic costs of NAFLD: a global framework to navigate the uncertainties","volume":"79","author":"Allen","year":"2023","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101722_bib34","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2023.04.035","article-title":"A global research priority agenda to advance public health responses to fatty liver disease","volume":"79","author":"Lazarus","year":"2023","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101722_bib35","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jhep.2021.10.025","article-title":"The global NAFLD policy review and preparedness index: are countries ready to address this silent public health challenge?","volume":"76","author":"Lazarus","year":"2022","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.lanepe.2026.101722_bib36","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.cgh.2023.04.007","article-title":"Artificial intelligence applications in hepatology","volume":"21","author":"Schattenberg","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.lanepe.2026.101722_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2026.01.016","article-title":"Diagnostic accuracy of noninvasive tests for metabolic dysfunction-associated steatotic liver disease across age, type 2 diabetes, and obesity subgroups: a multinational study","author":"Younossi","year":"2026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.lanepe.2026.101722_bib38","article-title":"Global performance of non-invasive tests in MASLD: insights from the G-MASLD study","author":"Younossi","year":"2025","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101722_bib39","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/hep.32545","article-title":"The steatosis-associated fibrosis estimator (SAFE) score: a tool to detect low-risk NAFLD in primary care","volume":"77","author":"Sripongpun","year":"2023","journal-title":"Hepatology"},{"issue":"10406","key":"10.1016\/j.lanepe.2026.101722_bib40","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0140-6736(23)01174-1","article-title":"Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study","volume":"402","author":"Serra-Burriel","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101722_bib41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/j.gastro.2024.03.017","article-title":"Metabolic dysfunction-associated fibrosis 5 (MAF-5) score predicts liver fibrosis risk and outcome in the general population with metabolic dysfunction","volume":"167","author":"van Kleef","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lanepe.2026.101722_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-083182","article-title":"Use of new CORE risk score to predict 10 year risk of liver cirrhosis in general population: population based cohort study","volume":"390","author":"Strandberg","year":"2025","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101722_bib43","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16240","article-title":"Precision in liver diagnosis: varied accuracy across subgroups and the need for variable thresholds in diagnosis of MASLD","volume":"45","author":"Vali","year":"2025","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101722_bib44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2023.04.002","article-title":"Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease","volume":"79","author":"Kjaergaard","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.lanepe.2026.101722_bib45","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000001342","article-title":"Advances in imaging-Elastography","author":"Dajti","year":"2025","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101722_bib46","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.29302","article-title":"Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis","volume":"66","author":"Xiao","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101722_bib47","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/HEP.0000000000000351","article-title":"Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes","volume":"78","author":"Pennisi","year":"2023","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.lanepe.2026.101722_bib48","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.cgh.2021.12.034","article-title":"Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population","volume":"20","author":"Graupera","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101722_bib49","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jhep.2021.12.031","article-title":"Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events","volume":"76","author":"Boursier","year":"2022","journal-title":"J Hepatol"},{"issue":"22","key":"10.1016\/j.lanepe.2026.101722_bib50","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.3390\/diagnostics14222478","article-title":"An assessment of the feasibility, patient acceptance, and performance of point-of-care transient elastography for metabolic-dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis","volume":"14","author":"Sarkar Das","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"10.1016\/j.lanepe.2026.101722_bib51","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/NNR.0000000000000001","article-title":"Using transient elastography to detect chronic liver diseases in a primary care nurse consultancy","volume":"62","author":"Fabrellas","year":"2013","journal-title":"Nurs Res"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101722_bib52","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/jalm\/jfaa109","article-title":"Intelligent liver function testing: working smarter to improve patient outcomes in liver disease","volume":"5","author":"Macpherson","year":"2020","journal-title":"J Appl Lab Med"},{"issue":"9","key":"10.1016\/j.lanepe.2026.101722_bib53","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3390\/diagnostics14090960","article-title":"Intelligent liver function testing (iLFT): an intelligent laboratory approach to identifying chronic liver disease","volume":"14","author":"Nobes","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"10315","key":"10.1016\/j.lanepe.2026.101722_bib54","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0140-6736(21)00673-5","article-title":"The Lancet Commission on diagnostics: transforming access to diagnostics","volume":"398","author":"Fleming","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.lanepe.2026.101722_bib55","article-title":"Prevalence of fibrosis and applicability of lab-based noninvasive tests from primary to tertiary care","volume":"16","author":"Semmler","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.lanepe.2026.101722_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fdgth.2022.737729","article-title":"Health technology adoption in liver disease: innovative use of data science solutions for early disease detection","volume":"4","author":"Bennett","year":"2022","journal-title":"Front Digit Health"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101722_bib57","article-title":"Physical activity is associated with reduced risk of liver disease in the prospective UK Biobank cohort","volume":"3","author":"Schneider","year":"2021","journal-title":"JHEP Rep"},{"issue":"8","key":"10.1016\/j.lanepe.2026.101722_bib58","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.cgh.2021.04.024","article-title":"Health equity and telemedicine in gastroenterology and hepatology","volume":"19","author":"Wegermann","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101722_bib59","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jhep.2024.03.035","article-title":"Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases","volume":"81","author":"Thiele","year":"2024","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.lanepe.2026.101722_bib60","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1038\/s41591-024-03284-0","article-title":"Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Jamialahmadi","year":"2024","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101722_bib61","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3350\/cmh.2024.0229","article-title":"DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Magdy","year":"2024","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101722_bib62","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s12913-025-12580-5","article-title":"Implementation of a nurse-delivered, community-based liver screening and assessment program for people with metabolic dysfunction-associated steatotic liver disease (LOCATE-NAFLD trial)","volume":"25","author":"Allen","year":"2025","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101722_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2024.101741","article-title":"A social media listening study of patients' experiences relating to metabolic dysfunction-associated steatotic liver disease: the LISTEN-MASLD study","volume":"30","author":"Lazarus","year":"2025","journal-title":"Ann Hepatol"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101722_bib64","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41746-025-02178-w","article-title":"Meeting the challenges of electronic health record (EHR) optimization","volume":"9","author":"Makhni","year":"2025","journal-title":"NPJ Digit Med"},{"issue":"8","key":"10.1016\/j.lanepe.2026.101722_bib65","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1111\/liv.15941","article-title":"Use of non-invasive diagnostic tools for metabolic dysfunction-associated steatohepatitis: a qualitative exploration of challenges and barriers","volume":"44","author":"Tsochatzis","year":"2024","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101722_bib66","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000678","article-title":"Global patterns of utilization of noninvasive tests for the clinical management of metabolic dysfunction-associated steatotic liver disease","volume":"9","author":"Allen","year":"2025","journal-title":"Hepatol Commun"},{"issue":"7","key":"10.1016\/j.lanepe.2026.101722_bib67","article-title":"The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease","volume":"6","author":"Younossi","year":"2024","journal-title":"JHEP Rep"},{"issue":"10","key":"10.1016\/j.lanepe.2026.101722_bib68","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41575-024-00959-4","article-title":"Food inequity and insecurity and MASLD: burden, challenges, and interventions","volume":"21","author":"Zelber-Sagi","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101722_bib69","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1186\/s12913-020-05760-y","article-title":"Time trends in the regional distribution of physicians, nurses and midwives in Europe","volume":"20","author":"Winkelmann","year":"2020","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101722_bib71","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-092731","article-title":"Global research initiative for patient screening on MASH (GRIPonMASH) protocol: rationale and design of a prospective multicentre study","volume":"15","author":"de Jong","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.lanepe.2026.101722_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2025.101674","article-title":"Name MASLD\/MASH \u2014 and act on it","author":"Lazarus","year":"2026","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101722_bib73","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.124.070535","article-title":"Cardiovascular-liver-metabolic health: recommendations in screening, diagnosis, and management of metabolic dysfunction-associated steatotic liver disease in cardiovascular disease via modified Delphi approach","volume":"151","author":"Chew","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.lanepe.2026.101722_bib74","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s44360-025-00042-5","article-title":"A call to action from the Global Think-tank on Steatotic Liver Disease","volume":"1","author":"Lazarus","year":"2026","journal-title":"Nat Health"},{"issue":"12","key":"10.1016\/j.lanepe.2026.101722_bib75","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1515\/cclm-2024-1022","article-title":"A vision to the future: value-based laboratory medicine","volume":"62","author":"Plebani","year":"2024","journal-title":"Clin Chem Lab Med"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776226001341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776226001341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T20:05:38Z","timestamp":1783195538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776226001341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":74,"alternative-id":["S2666776226001341"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101722","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver disease","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101722","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101713","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101739","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101723","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101731","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101742","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101712","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101707","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101722"}}